← Back to Clinical Trials
Recruiting NCT04809740
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
Trial Parameters
Condition Cancer
Sponsor University of Alabama at Birmingham
Study Type INTERVENTIONAL
Phase N/A
Enrollment 7,500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-05-04
Completion 2026-12
Interventions
Evaluate implementation of navigator-delivered Home ePRO for all cancer patients
Brief Summary
1\) Evaluate implementation of navigator-delivered Home ePRO for all cancer patients across multiple practice sites; 2) examine the barriers, facilitators, and implementation strategies used in implementing navigator-delivered Home ePRO; and 3) assess the impact of Home ePRO on clinical and utilization outcomes.
Eligibility Criteria
Inclusion Criteria: Patient Group: * Age ≥18 * Cancer patients at participating institution * Receipt of chemotherapy, targeted therapy, and immunotherapy at participating institution from 2019-2026. Exclusion Criteria: \- Second opinion only at participating institution.